CN Patent

CN113735862A — 一种治疗病毒感染的核苷类化合物及其用途

Assigned to Southern University of Science and Technology · Expires 2021-12-03 · 4y expired

What this patent protects

一种治疗冠状病毒感染的核苷类化合物及其前药，具有式I所述的化合物、其前药和/或其药学上可接受的盐，及其组合物和用途。所述化合物和组合物具有预防、缓解或治疗冠状病毒感染，或其同源变异病毒的复制或繁殖及其所产生的细胞病变效应的用途。

USPTO Abstract

一种治疗冠状病毒感染的核苷类化合物及其前药，具有式I所述的化合物、其前药和/或其药学上可接受的盐，及其组合物和用途。所述化合物和组合物具有预防、缓解或治疗冠状病毒感染，或其同源变异病毒的复制或繁殖及其所产生的细胞病变效应的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN113735862A
Jurisdiction
CN
Classification
—
Expires
2021-12-03
Drug substance claim
No
Drug product claim
No
Assignee
Southern University of Science and Technology
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.